“Children deserve our protection, not experimental interventions that pose serious risks and convey no proven benefits...”

HHS finalized a rule prohibiting Medicaid payments for child gender medicine, including puberty blockers, cross-sex hormones, and surgeries.

El gobierno ha tomado la decisión al concluir que existen «importantes lagunas en la evidencia» que demostraba la seguridad de estos tratamientos